Clinical Trial Update: A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study update evaluating Jinyebaidu Granule for acute upper respiratory infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Infection

Drugs mentioned

• Jinyebaidu Granule

Snippet

Sponsor: China Academy of Chinese Medical Sciences | Conditions: Acute Upper Respiratory Infection | Phase 4 | Status: UNKNOWN